Since the U.S. Environmental Protection Agency began widespread monitoring of PM2.5 levels in 1999, the epidemiologic community has performed numerous observational studies modeling mortality and morbidity responses to PM2.5 levels using Poisson generalized additive models (GAMs).
Thus, in both groups we obtained information from each patient record about the following variables allegedly affecting LOS: age, sex; place of residence, marital status, main diagnosis, administered medications, use of electroconvulsive therapy, co morbidities, response to treatment and symptoms at admission.
The result supports the use of CVD ED syndromic series as a near-real time health outcome indicator of CVD morbidity in response to exposure to environmental risk factors.
This low absolute incidence combined with high morbidity, poor response rates and short survival times pose practical problems for clinical trial execution, particularly if therapy is anticipated to target a molecularly-defined subset of tumors.
All patients with carcinoma of the breast seen in this Unit since 1970 were reviewed to study the incidence, prognosis, morbidity and response to treatment of bone metastases.
This could indicate that specific microorganism-driven immunoglobulin production is more likely to cause inflammatory brain damage resulting in neurological morbidity than response to neoplastic cells in LM [ 20].
As previously [ 7], we derive our selected morbidity concentration-response estimates from recent US EPA benefit-cost analyses [ 16, 17].
The underlying disease, the presence of co-morbidity, the response to initial treatment, and the development of adverse effects should influence treatment decisions.
Although this clinical syndrome is heterogeneous with regard to factors such as causal micro-organism, patient predisposition, co-morbidity and response to therapy, a key element and unifying feature is the manifestation of cardiovascular dysfunction.
These annotations identified five main areas of difficulty that patients experienced: lack of question clarity (particularly concerning the use of aids), difficulty in reporting measurements of pain, restrictive and irrelevant questions, the influence of co-morbidities on responses, and double-barrelled questions.
This article outlines treatment-related morbidity and PSA response to this regimen and analyzes the effect of escalating doses of brachytherapy.
